Augmedix vs Amgen

Side-by-side comparison of AI visibility scores, market position, and capabilities

Amgen leads in AI visibility (88 vs 52)
Augmedix logo

Augmedix

GrowthHealthTech

Remote Medical Scribing

San Francisco medical documentation company combining AI transcription with remote human scribes to produce EHR notes from physician-patient encounters in real time via smartphone or Glass.

AI VisibilityBeta
Overall Score
C52
Category Rank
#283 of 596
AI Consensus
86%
Trend
stable
Per Platform
ChatGPT
56
Perplexity
52
Gemini
57

About

Augmedix is a San Francisco-based medical documentation company that combines AI transcription technology with remote human scribes to document physician-patient encounters in real time, producing complete EHR notes that physicians review and sign. Physicians wear Google Glass or use a smartphone to stream audio and video of patient encounters to Augmedix's platform, where remote scribes observe and document the visit, supported by AI tools that transcribe speech and suggest note structures. This hybrid AI-plus-human model enables documentation quality and customization that pure AI solutions struggle to achieve for complex clinical encounters, while still dramatically reducing the time physicians spend on documentation. Augmedix serves large health systems and multispecialty groups, with customer deployments across hundreds of physicians. The company went public via merger with LifeSci Acquisition in 2020 and was subsequently acquired by Nuvation Bio. Augmedix competes with Nuance DAX, Suki, and traditional medical transcription services in the clinical documentation market.

Full profile
Amgen logo

Amgen

LeaderHealthcare Tech

AI Drug Discovery

Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.

AI VisibilityBeta
Overall Score
A88
Category Rank
#3 of 596
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
83
Perplexity
87
Gemini
85

About

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.

Full profile

AI Visibility Head-to-Head

52
Overall Score
88
#283
Category Rank
#3
86
AI Consensus
78
stable
Trend
stable
56
ChatGPT
83
52
Perplexity
87
57
Gemini
85
53
Claude
90
52
Grok
92

Key Details

Category
Remote Medical Scribing
AI Drug Discovery
Tier
Growth
Leader
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only Augmedix
Remote Medical Scribing
Only Amgen
AI Drug Discovery

Integrations

Amgen is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.